Linked Data API

Show Search Form

Search Results

1204449
registered interest false more like this
date less than 2020-06-16more like thismore than 2020-06-16
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the methodology used by NICE to appraise combination therapies in the ongoing NICE Methods Review. more like this
tabling member constituency Nottingham North more like this
tabling member printed
Alex Norris more like this
uin 59876 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-07-07more like thismore than 2020-07-07
answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods it uses in developing its guidance. While NICE is currently undertaking a review of its methods for health technology evaluation, the review is not considering combination treatments as a specific topic.</p><p>Commercial and policy-related challenges for combination treatments are being explored in other projects in line with the commitments in the Voluntary Scheme for Branded Medicines Pricing and Access. As stated in the Scheme, the Department and NHS England and NHS Improvement will support the Association of the British Pharmaceutical Industry’s efforts to find solutions to these challenges.</p><p> </p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2020-07-07T15:03:10.697Zmore like thismore than 2020-07-07T15:03:10.697Z
answering member
4380
label Biography information for Jo Churchill more like this
previous answer version
31043
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4641
label Biography information for Alex Norris more like this
1186534
registered interest false more like this
date less than 2020-03-19more like thismore than 2020-03-19
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will support the National Institute for Health and Care Excellence to undertake its methods and processes in a way that (a) enables the attractiveness of the UK as a place to conduct clinical trials or supply human medicines and (b) enables that organisation to fulfil its statutory duty to promote innovation. more like this
tabling member constituency Reigate more like this
tabling member printed
Crispin Blunt more like this
uin 32039 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-05-29more like thismore than 2020-05-29
answer text <p>The National Institute for Health and Care Excellence (NICE) is reviewing its methods for the development of technology appraisal and highly specialised technology recommendations in line with the commitment in the 2019 voluntary scheme for branded medicines pricing and access. The scheme also states the Government’s expectations for the review as follows: ‘“The Department expects that any future changes to NICE methods and processes would respond to the new types of innovation coming to the market, be consistent with improving the health gain achieved by spending on new innovative medicines, and support faster adoption of the most clinically and cost effective medicines.”’</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 32038 more like this
question first answered
less than 2020-05-29T16:49:06.817Zmore like thismore than 2020-05-29T16:49:06.817Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
104
label Biography information for Crispin Blunt more like this
1175547
registered interest true more like this
date less than 2020-02-03more like thismore than 2020-02-03
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, which patient organisations are members of the (a) modifiers considered in decision-making, (b) exploring uncertainty, (c) types of evidence, (d) health-related quality of life, (e) technology specific issues, (f) discounting, (g) cost-minimisation methods (h) costs used in HTA, (i) equality considerations in guideline development, (j) general approach to decision-making and (k) position of technologies in care pathway, NICE methods review task and finish groups. more like this
tabling member constituency Sheffield South East more like this
tabling member printed
Mr Clive Betts more like this
uin 11443 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-06more like thismore than 2020-02-06
answer text <p>The following patient groups are currently involved across the programme of task and finish groups. The National Institute for Health and Care Excellence (NICE) has advised that it continues to seek further members for the task and finish groups, and a full list of members is still to be finalised.</p><p>- Alzheimer's Research UK;</p><p>- Breast Cancer Now;</p><p>- Cancer52;</p><p>- Cystic Fibrosis Trust ;</p><p>- Diabetes UK;</p><p>- Genetic Alliance UK;</p><p>- Leukaemia CARE;</p><p>- Multiple Sclerosis Society;</p><p>- Muscular Dystrophy UK;</p><p>- Myeloma UK;</p><p>- Neuroendocrine Cancer UK;</p><p>- Prostate cancer UK; and</p><p>- Sarcoma UK.</p><p> </p><p>In recruiting patient organisations to the NICE methods review task and finish groups, patients on the methods working group were asked to nominate representatives with a range of experience. Additional representatives were nominated by NICE where particular expertise or input was required. The organisations involved in the task and finish groups cover a broad spectrum of disease areas including cancer, non-cancer and rare diseases.<strong> </strong></p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 11444 more like this
question first answered
less than 2020-02-06T17:20:14.56Zmore like thismore than 2020-02-06T17:20:14.56Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
394
label Biography information for Mr Clive Betts more like this
1175548
registered interest true more like this
date less than 2020-02-03more like thismore than 2020-02-03
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how patient organisations were recruited to the 11 NICE methods review task and finish groups. more like this
tabling member constituency Sheffield South East more like this
tabling member printed
Mr Clive Betts more like this
uin 11444 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-06more like thismore than 2020-02-06
answer text <p>The following patient groups are currently involved across the programme of task and finish groups. The National Institute for Health and Care Excellence (NICE) has advised that it continues to seek further members for the task and finish groups, and a full list of members is still to be finalised.</p><p>- Alzheimer's Research UK;</p><p>- Breast Cancer Now;</p><p>- Cancer52;</p><p>- Cystic Fibrosis Trust ;</p><p>- Diabetes UK;</p><p>- Genetic Alliance UK;</p><p>- Leukaemia CARE;</p><p>- Multiple Sclerosis Society;</p><p>- Muscular Dystrophy UK;</p><p>- Myeloma UK;</p><p>- Neuroendocrine Cancer UK;</p><p>- Prostate cancer UK; and</p><p>- Sarcoma UK.</p><p> </p><p>In recruiting patient organisations to the NICE methods review task and finish groups, patients on the methods working group were asked to nominate representatives with a range of experience. Additional representatives were nominated by NICE where particular expertise or input was required. The organisations involved in the task and finish groups cover a broad spectrum of disease areas including cancer, non-cancer and rare diseases.<strong> </strong></p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 11443 more like this
question first answered
less than 2020-02-06T17:20:14.623Zmore like thismore than 2020-02-06T17:20:14.623Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
394
label Biography information for Mr Clive Betts more like this
1175549
registered interest true more like this
date less than 2020-02-03more like thismore than 2020-02-03
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps the NICE methods review task and finish groups will take to consult with the wider health charity sector. more like this
tabling member constituency Sheffield South East more like this
tabling member printed
Mr Clive Betts more like this
uin 11445 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-06more like thismore than 2020-02-06
answer text <p>The National Institute for Heath and Care Excellence (NICE) has advised that a six week public consultation on the proposals for changing its methods and processes will take place this summer. We understand that further work on the timetable is in progress and will be communicated in due course.</p><p>The wider health charity sector will have an opportunity to review the proposals for change from the task and finish groups during this consultation.</p><p>NICE also held a webinar with stakeholders in November 2019 to share how and why health technology evaluation is changing and what it means for patients. The webinar is available on the NICE website at the following link:</p><p><a href="https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation" target="_blank">https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation</a></p><p>NICE staff have also participated in a number of events to engage with the patient community, including the charity sector and about the methods review.</p><p><strong> </strong></p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 11446 more like this
question first answered
less than 2020-02-06T17:21:30.47Zmore like thismore than 2020-02-06T17:21:30.47Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
394
label Biography information for Mr Clive Betts more like this
1175550
registered interest true more like this
date less than 2020-02-03more like thismore than 2020-02-03
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the full consultation on the proposed reforms to NICE methods and processes. more like this
tabling member constituency Sheffield South East more like this
tabling member printed
Mr Clive Betts more like this
uin 11446 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2020-02-06more like thismore than 2020-02-06
answer text <p>The National Institute for Heath and Care Excellence (NICE) has advised that a six week public consultation on the proposals for changing its methods and processes will take place this summer. We understand that further work on the timetable is in progress and will be communicated in due course.</p><p>The wider health charity sector will have an opportunity to review the proposals for change from the task and finish groups during this consultation.</p><p>NICE also held a webinar with stakeholders in November 2019 to share how and why health technology evaluation is changing and what it means for patients. The webinar is available on the NICE website at the following link:</p><p><a href="https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation" target="_blank">https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation</a></p><p>NICE staff have also participated in a number of events to engage with the patient community, including the charity sector and about the methods review.</p><p><strong> </strong></p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
grouped question UIN 11445 more like this
question first answered
less than 2020-02-06T17:21:30.533Zmore like thismore than 2020-02-06T17:21:30.533Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
394
label Biography information for Mr Clive Betts more like this
1145510
registered interest false more like this
date less than 2019-09-24more like thismore than 2019-09-24
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will publish the roles of the members of the (a) steering group, (b) working group and (c) each of the task and finish groups for NICE's review into its methods and processes. more like this
tabling member constituency Scunthorpe more like this
tabling member printed
Nic Dakin more like this
uin 290336 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-30more like thismore than 2019-09-30
answer text <p>The steering group and working group members and their roles are published on the National Institute for Health and Care Excellence (NICE) website at the following link:</p><p><a href="https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation" target="_blank">https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/changes-to-health-technology-evaluation</a></p><p>NICE has advised the Department that it plans to publish the names of those people involved in the task and finish groups on its website as soon as they are confirmed.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-09-30T17:05:30.34Zmore like thismore than 2019-09-30T17:05:30.34Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4056
label Biography information for Nic Dakin more like this
1142187
registered interest false more like this
date less than 2019-07-25more like thismore than 2019-07-25
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he publish the names of the members of the (a) steering group, (b) working group and (c) each of the task and finish groups for NICE’s review into its methods and processes. more like this
tabling member constituency Scunthorpe more like this
tabling member printed
Nic Dakin more like this
uin 282320 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> more like this
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-09-09T17:52:02.1Zmore like thismore than 2019-09-09T17:52:02.1Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
4056
label Biography information for Nic Dakin more like this
1131740
registered interest false more like this
date less than 2019-06-12more like thismore than 2019-06-12
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, which topics have been identified for inclusion in the upcoming review of the appraisal methods used by NICE. more like this
tabling member constituency Cambridge more like this
tabling member printed
Daniel Zeichner more like this
uin 263870 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-06-20more like thismore than 2019-06-20
answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes used in the development of its technology appraisal and highly specialised technologies recommendations. NICE has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry and other relevant stakeholders will be active participants in the review, including inputting on scope, participating in working discussions, and providing views on recommendations. NICE’s updated methods guide will also be subject to a public consultation.</p><p> </p><p>NICE has established a working group, consisting of members from NICE, NHS England, the Department, patient organisations and the life sciences industry. The working group reports to a steering group, chaired by NICE and with members from NHS England, the Department, and an independent academic methodologist. The steering group will present its recommendations to NICE’s Senior Management Team, which in turn will report to the NICE Board. NICE approached patient groups with experience of NICE and its processes and methods. There are three patient group representatives on the working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Membership of the working group will be published in due course.</p><p> </p><p>NICE is now in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations with input from the working group and steering group. The scope of the review - a list of the aspects of NICE’s current methods that will be considered in the review - will be presented to the NICE Board in July. Additional detail and more information will be made available on the NICE website in due course. NICE anticipates being in a position to confirm the revised methods guide by the end of 2020, following public consultation.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
grouped question UIN
263871 more like this
263872 more like this
263873 more like this
263874 more like this
question first answered
less than 2019-06-20T13:18:08.087Zmore like thismore than 2019-06-20T13:18:08.087Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4382
label Biography information for Daniel Zeichner more like this
1131742
registered interest false more like this
date less than 2019-06-12more like thismore than 2019-06-12
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what the timescale is for NICE's Methods review. more like this
tabling member constituency Cambridge more like this
tabling member printed
Daniel Zeichner more like this
uin 263871 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-06-20more like thismore than 2019-06-20
answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes used in the development of its technology appraisal and highly specialised technologies recommendations. NICE has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry and other relevant stakeholders will be active participants in the review, including inputting on scope, participating in working discussions, and providing views on recommendations. NICE’s updated methods guide will also be subject to a public consultation.</p><p> </p><p>NICE has established a working group, consisting of members from NICE, NHS England, the Department, patient organisations and the life sciences industry. The working group reports to a steering group, chaired by NICE and with members from NHS England, the Department, and an independent academic methodologist. The steering group will present its recommendations to NICE’s Senior Management Team, which in turn will report to the NICE Board. NICE approached patient groups with experience of NICE and its processes and methods. There are three patient group representatives on the working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Membership of the working group will be published in due course.</p><p> </p><p>NICE is now in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations with input from the working group and steering group. The scope of the review - a list of the aspects of NICE’s current methods that will be considered in the review - will be presented to the NICE Board in July. Additional detail and more information will be made available on the NICE website in due course. NICE anticipates being in a position to confirm the revised methods guide by the end of 2020, following public consultation.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
grouped question UIN
263870 more like this
263872 more like this
263873 more like this
263874 more like this
question first answered
less than 2019-06-20T13:18:08.15Zmore like thismore than 2019-06-20T13:18:08.15Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4382
label Biography information for Daniel Zeichner more like this